12:23 PM EST - Revitalist Lifestyle : Announced its research division has received independent institutional review board approval from the highly renowned Biomedical Research Alliance of New York. IRB approval from BRANY will facilitate clinical trials at all nine Revitalist clinics, development of proprietary data, and partnerships advancing the field of psychedelics. BRANY has been serving academic medical centers, research organizations, and research sites for over 20 years. Revitalist Lifestyle
shares C.CALM are trading down 0.01 cent at $0.08.
